Nabla, a leading ambient AI assistant for practitioners, has recently closed a $24 million Series B funding round to support its expansion and revolutionize healthcare delivery. The funding round was led by Cathay Innovation, with participation from ZEBOX Ventures, bringing Nabla’s total funding to over $43 million.
One of the major challenges for clinicians is managing electronic health records (EHR). The time-intensive task of clinical documentation adds an extra six hours per week of EHR work for practitioners outside of the time spent with patients. To address this issue, Nabla’s AI-powered assistant, called Nabla Copilot, offers note-generation capabilities, medical coding recognition, and smooth integrations with EHR systems. This saves clinicians valuable time, allowing them to focus on providing care to their patients. The AI assistant’s notes are highly precise, requiring adjustments in only 5% of cases.
With the new funding, Nabla aims to expand its presence across U.S. healthcare systems and continue developing its ambient AI assistant to support clinicians in various aspects of care delivery, including medical decision support. The investment will also enable Nabla to improve health equity by introducing additional language options for Nabla Copilot.
Since its official launch less than ten months ago, Nabla has already achieved impressive results. The company reports that three million consultations are conducted annually through Nabla Copilot, and over 20,000 healthcare providers have adopted the AI assistant, providing positive reviews that demonstrate its impact.
Nabla’s scalability is another advantage, as it can cater to the unique needs of both small practices and large health systems with thousands of clinicians. The company has also partnered with EHR platforms to facilitate the widespread use of Nabla Copilot, given the increasing demand for AI solutions that streamline workflows while ensuring privacy, accuracy, and speed.
Established in 2018, Nabla has developed proprietary Large Language Models (LLM) and Speech-to-Text (STT) technologies with the expertise of former Facebook AI Research engineers. The company benefits from the advice of AI and medical experts, including Yann LeCun, known as the godfather of AI, and renowned practitioners and professors in the field.
In conclusion, Nabla’s recent funding will propel the company’s mission to create a premier ambient AI assistant that brings joy back to clinicians’ practices. By tackling the challenges of clinical documentation and expanding its capabilities, Nabla is set to transform healthcare delivery and support healthcare teams worldwide.
